BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19349112)

  • 1. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
    Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
    Schramm A; Vandesompele J; Schulte JH; Dreesmann S; Kaderali L; Brors B; Eils R; Speleman F; Eggert A
    Clin Cancer Res; 2007 Mar; 13(5):1459-65. PubMed ID: 17332289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
    Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
    J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
    De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
    Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
    Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
    Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
    Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling.
    Castells X; García-Gómez JM; Navarro A; Acebes JJ; Godino O; Boluda S; Barceló A; Robles M; Ariño J; Arús C
    Diagn Mol Pathol; 2009 Dec; 18(4):206-18. PubMed ID: 19861896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
    J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.
    Schramm A; Schulte JH; Klein-Hitpass L; Havers W; Sieverts H; Berwanger B; Christiansen H; Warnat P; Brors B; Eils J; Eils R; Eggert A
    Oncogene; 2005 Nov; 24(53):7902-12. PubMed ID: 16103881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.
    Rème T; Hose D; De Vos J; Vassal A; Poulain PO; Pantesco V; Goldschmidt H; Klein B
    BMC Bioinformatics; 2008 Jan; 9():16. PubMed ID: 18190711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.
    Schulte JH; Schowe B; Mestdagh P; Kaderali L; Kalaghatgi P; Schlierf S; Vermeulen J; Brockmeyer B; Pajtler K; Thor T; de Preter K; Speleman F; Morik K; Eggert A; Vandesompele J; Schramm A
    Int J Cancer; 2010 Nov; 127(10):2374-85. PubMed ID: 20473924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage II colon cancer prognosis prediction by tumor gene expression profiling.
    Barrier A; Boelle PY; Roser F; Gregg J; Tse C; Brault D; Lacaine F; Houry S; Huguier M; Franc B; Flahault A; Lemoine A; Dudoit S
    J Clin Oncol; 2006 Oct; 24(29):4685-91. PubMed ID: 16966692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
    Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
    Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
    Sun Z; Yang P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile class prediction using linear Bayesian classifiers.
    Asyali MH
    Comput Biol Med; 2007 Dec; 37(12):1690-9. PubMed ID: 17517385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
    Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.